|62.77||+1.67||+2.73%||Vol 502.77K||1Y Perf 8.56%|
|Oct 4th, 2023 16:00 DELAYED|
|- -||-0.65 -1.04%|
|Target Price||73.50||Analyst Rating||Moderate Buy 2.11|
|Potential %||17.09||Finscreener Ranking||★★ 46.39|
|Insiders Trans % 3/6/12 mo.||100/-60/-82||Value Ranking||★★ 45.83|
|Insiders Value % 3/6/12 mo.||100/-97/-100||Growth Ranking||★★★★ 59.78|
|Insiders Shares Cnt. % 3/6/12 mo.||100/-97/-99||Income Ranking||+ 26.30|
|Price Range Ratio 52W %||32.34||Earnings Rating||Sell|
|Market Cap||9.22B||Earnings Date||2nd Nov 2023|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Sell|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||2nd Nov 2023|
|Estimated EPS Next Report||0.63|
|EPS Growth Next 5 Years %||18.50|
|Avg. Weekly Volume||556.14K|
|Avg. Monthly Volume||927.56K|
|Avg. Quarterly Volume||868.33K|
Bruker Corporation (NASDAQ: BRKR) stock closed at 62.77 per share at the end of the most recent trading day (a 2.73% change compared to the prior day closing price) with a volume of 502.77K shares and market capitalization of 9.22B. Is a component of Russell 1000 indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 7230 people. Bruker Corporation CEO is Frank H. Laukien.
The one-year performance of Bruker Corporation stock is 8.56%, while year-to-date (YTD) performance is -8.16%. BRKR stock has a five-year performance of 86.82%. Its 52-week range is between 52.22 and 84.84, which gives BRKR stock a 52-week price range ratio of 32.34%
Bruker Corporation currently has a PE ratio of 37.00, a price-to-book (PB) ratio of 10.58, a price-to-sale (PS) ratio of 5.29, a price to cashflow ratio of 42.00, a PEG ratio of 2.00, a ROA of 9.18%, a ROC of 13.77% and a ROE of 29.75%. The company’s profit margin is 10.99%, its EBITDA margin is 20.90%, and its revenue ttm is $1.82 Billion , which makes it $12.39 revenue per share.
Of the last four earnings reports from Bruker Corporation, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.63 for the next earnings report. Bruker Corporation’s next earnings report date is 02nd Nov 2023.
The consensus rating of Wall Street analysts for Bruker Corporation is Moderate Buy (2.11), with a target price of $73.5, which is +17.09% compared to the current price. The earnings rating for Bruker Corporation stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Bruker Corporation has a dividend yield of 0.31% with a dividend per share of $0.20 and a payout ratio of 12.00%.
Bruker Corporation has a Sell technical analysis rating based on Technical Indicators (ADX : 14.60, ATR14 : 1.71, CCI20 : -86.02, Chaikin Money Flow : -0.10, MACD : -0.98, Money Flow Index : 48.89, ROC : -8.02, RSI : 39.44, STOCH (14,3) : 3.43, STOCH RSI : 0.00, UO : 40.25, Williams %R : -96.57), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Bruker Corporation in the last 12-months were: Cynthia M. Friend (Sold 921 shares of value $62 867 ), Frank H. Laukien (Sold 1 000 000 shares of value $77 623 552 ), Friend Cynthia (Sold 921 shares of value $62 867 ), Herman Gerald (Sold 14 242 shares of value $1 074 131 ), Kastner Marc (Sold 11 146 shares of value $838 402 ), Marc A. Kastner (Option Excercise at a value of $240 000), Marc A. Kastner (Sold 10 000 shares of value $707 490 ), Richard A. Packer (Option Excercise at a value of $164 200), Richard A. Packer (Sold 20 000 shares of value $1 323 660 ), William A. Linton (Option Excercise at a value of $164 200)
Tue, 22 Aug 2023 20:11 GMT PhenomeX downgraded to Market Perform from Outperform at TD Cowen- TipRanks. All rights reserved.
Copyright © 2016-2023 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
General partner of Finscreener is SLOVAKODATA, a.s.
This could take some time, please wait.